Company Filing History:
4 out of 870 
1 out of 531 
Years Active: 2019-2023
Title: Innovations of Muhamed-Kheir Taha
Introduction
Muhamed-Kheir Taha is a notable inventor based in Saint Maur des Fosses, France. He has made significant contributions to the field of diagnostics, particularly in the development of polyclonal antibodies. With a total of four patents to his name, Taha's work has the potential to impact medical diagnostics significantly.
Latest Patents
Taha's latest patents focus on polyclonal antibodies specific for serogroup X of Neisseria meningitidis. These antibodies are designed for in vitro detection of serogroup X in biological fluids without the need for culture. The inventions also include various diagnostic tests and methods to detect NmX. Additionally, Taha has developed a rapid diagnostic test for detecting NmX in biological fluids, as well as methods for obtaining these polyclonal antibodies from cerebrospinal fluid, serum, and urine.
Career Highlights
Throughout his career, Taha has worked with prestigious organizations such as Institut Pasteur and GlaxoSmithKline Biologicals. His experience in these institutions has contributed to his expertise in the field of immunology and diagnostics.
Collaborations
Taha has collaborated with notable colleagues, including Alain Agnememel and Francois Traincard. These partnerships have likely enhanced his research and development efforts in the field of diagnostics.
Conclusion
Muhamed-Kheir Taha's innovative work in developing polyclonal antibodies for diagnostic purposes showcases his significant contributions to medical science. His patents reflect a commitment to improving diagnostic methods, which can lead to better healthcare outcomes.